Global Health Technologies Coalition (GHTC)
banner
ghtcoalition.org
Global Health Technologies Coalition (GHTC)
@ghtcoalition.org
Our mission is to advance innovation to save lives. GHTC is the leading advocacy organization working to accelerate R&D for #GlobalHealth technologies. #Innovate4Health
R&D has been the bedrock of progress in #GlobalHealth. Tools developed through past R&D investments have improved the life expectancy of those living with #AIDS, driven remarkable declines in #ChildMortality, and nearly eradicated #polio. 👇🏼

www.ghtcoalition.org/why-research...
Why Research & Development | Global Health Technologies Coalition
Find out why research and development for new health technologies is an essential part of the solution to the world’s greatest global health challenges and one of the biggest drivers of health improve...
www.ghtcoalition.org
December 3, 2025 at 9:10 PM
Reposted by Global Health Technologies Coalition (GHTC)
⏰ REMINDER: Join the CARB-X team this week for public webinars to learn more about cycle two of the 2025 funding round! #IDSky 🧪

Thursday, 4 December at 19:00 ET
🔗 Register here: bit.ly/4nwr4ES

Friday, 5 December at 09:00 ET
🔗 Register here: bit.ly/4ofT6We
December 3, 2025 at 2:00 PM
Last week, Brazil’s regulatory agency approved the Butantan Institute’s Butantan-DV vaccine for #dengue for people aged 12 to 59.

www.ghtcoalition.org/blog/researc...
Research Roundup: Promising dengue antiviral, Dengue vaccine approval, Experimental flu mRNA vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
December 3, 2025 at 2:09 PM
The international architecture for #GlobalHealth is anything but simple. Our updated briefer breaks it down visually, showing how multilateral orgs contribute across the continuum of R&D. 💉 💊 🔬

www.ghtcoalition.org/resources-it...
Unpacking the Multilateral Architecture for Global Health R&D | GHTC
A complex network of multilateral organizations contributes to the research and development (R&D) and delivery of vaccines, treatments, diagnostics, and other technologies to advance global health. Th...
www.ghtcoalition.org
December 3, 2025 at 2:09 PM
Newly published data shows that the antiviral compound mosnodenvir, developed by Johnson & Johnson, is effective at preventing dengue infection in people deliberately exposed to the virus, which affects millions around the world every year.

www.ghtcoalition.org/blog/researc...
Research Roundup: Promising dengue antiviral, Dengue vaccine approval, Experimental flu mRNA vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
December 2, 2025 at 2:15 PM
Reposted by Global Health Technologies Coalition (GHTC)
🎗On World AIDS Day, we recognize that people living with HIV face a higher risk of drug-resistant bacterial infections.

GARDP continues its work to expand access to effective antibiotics and develop innovative treatments so that everyone receives the care they need.

#WorldAIDSDay #AMR
December 1, 2025 at 6:59 AM
Reposted by Global Health Technologies Coalition (GHTC)
📢 The CARB-X Portal is now open!

Submit an Expression of Interest to apply for CARB-X funding for new #therapeutics and #diagnostics to address drug-resistant bacteria. The deadline to apply is 12 December at 23:59 ET. 🧪 #AMR #IDSky

🔗 Apply now: bit.ly/3P56UDB   
December 1, 2025 at 3:00 PM
Reposted by Global Health Technologies Coalition (GHTC)
AVAC & partners will co-host the 8th Biomedical HIV Prevention Forum ahead of #ICASA2025, uniting advocates, researchers, civil society & govts to make choice-driven biomedical #HIV prevention a national priority. Join us, afnhi.org/bhpf-2025/#r...

@wacihealth.bsky.social @iasociety.bsky.social
December 1, 2025 at 3:56 PM
What's new in #GlobalHealth R&D?
💊Promising #dengue antiviral
🦟Dengue vaccine approval
💉Experimental flu mRNA vaccine

www.ghtcoalition.org/blog/researc...
Research Roundup: Promising dengue antiviral, Dengue vaccine approval, Experimental flu mRNA vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
December 1, 2025 at 5:23 PM
What's new in #GlobalHealth R&D?
💊 Shortened #TB regimen
🧫 New method to combat resistant bacteria using bacteriophages
🦠 Fungal pathogens test
www.ghtcoalition.org/blog/researc...
Research Roundup: Shortened TB regimen, New method using bacteriophages, Fungal pathogens test
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
November 24, 2025 at 2:38 PM
Global funding cuts made 2025 an incredibly challenging year for those at risk of or living with #HIV, as well as those advancing research. Yet, exciting breakthroughs have provided hope of renewed momentum in the global fight against HIV and AIDS. #WorldAIDSDay

www.ghtcoalition.org/blog/evolvin...
Evolving the global HIV/AIDS response: Emerging tools and new opportunities
International funding cuts and program closures have made 2025 an incredibly challenging year for those at risk of or living with HIV, as well as those advancing research on the virus. Yet amid this d...
www.ghtcoalition.org
November 21, 2025 at 3:32 PM
As we plan ahead for 2026, the busy fall season of high-level gatherings gave GHTC the change to reflect on the rapidly changing multilateral landscape and our role moving forward.

www.ghtcoalition.org/blog/staying...
Staying the course amid change: Reflections on a season of global health engagement
After a busy fall season of high-level gatherings for the global health community, GHTC shared reflections on our experiences at these convenings and how they are shaping our thinking about the coalit...
www.ghtcoalition.org
November 21, 2025 at 2:36 PM
South African pharmaceutical company Biovac is launching trials of a #cholera vaccine, which, if it proves successful, could become the first vaccine developed from start to finish on the African continent.

www.ghtcoalition.org/blog/researc...
Research Roundup: Rift Valley fever vaccine, Malaria treatment alternative, African-made cholera vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
November 20, 2025 at 7:05 PM
Reposted by Global Health Technologies Coalition (GHTC)
🌐 Amid funding cuts to #HIV programmes, #AIDS2026 will bring together communities, scientists, healthcare workers, policy makers, funders and media to rethink models, rebuild systems, and rise through innovation and inclusion.

👥 Learn more and join us in #Rio or virtually! #RethinkRebuildRise
AIDS 2026 overview | AIDS 2026
Location: Rio de Janeiro, Brazil and virtuallyDates: 26-31 July 2026; with pre-conferences starting on Sunday, 26 July Theme: Rethink. Rebuild. Rise. .block-text-description h3 span { font-weight: 200; }
www.iasociety.org
November 20, 2025 at 2:10 PM
Reposted by Global Health Technologies Coalition (GHTC)
Join WAHO, CEPI & partners for a webinar launching the Lassa Fever Research Agenda & open-access Repository—key tools to guide research, inform policy, and support timely, equitable vaccine introduction.

📅 25 Nov | 🕛 12:00 GMT
🔗 Register: bit.ly/4i8pYxT
November 20, 2025 at 2:52 PM
Reposted by Global Health Technologies Coalition (GHTC)
📊 2025 progress in GARDP’s Neonatal Sepsis programme

• The landmark #NeoSep1 trial now spans 9 hospitals across Africa & Asia, testing life-saving antibiotic combos for newborns with sepsis.
• Underway in South Africa, with more sites in preparation.

🔗https://bit.pulse.ly/pvvkvmxmpk

#WAAW2025
Landmark clinical trial for improving treatment options for newborns with sepsis to include nine countries | GARDP
Geneva, 12 June 2025 – A landmark clinical trial, aimed at evaluating life-saving antibiotic combination treatment options for newborns with sepsis, has been ex
bit.pulse.ly
November 20, 2025 at 4:00 PM
Reposted by Global Health Technologies Coalition (GHTC)
Unitaid and @mmv.org welcome @who.int’s prequalification of the first child-friendly primaquine formulations, a milestone that finally brings quality-assured pediatric options to children at highest risk of repeated malaria illness.

Find out more: unitaid.org/news-blog/wh...
November 19, 2025 at 9:47 AM
Reposted by Global Health Technologies Coalition (GHTC)
Gonorrhoea accounts for over 82 million new cases each year and has had no new treatment in more than 40 years.

GARDP and Innoviva Specialty Therapeutics have co-developed zoliflodacin, an investigational first-in-class oral antibiotic now under FDA review.

THIS IS BIG.

#WAAW2025 #AMR
November 19, 2025 at 1:00 PM
Reposted by Global Health Technologies Coalition (GHTC)
A new CEPI-funded initiative with LumaCyte
and IDT Biologika aims to overcome a major hurdle in vaccine manufacturing: the slow, complex process of potency testing.
November 19, 2025 at 2:58 PM
Reposted by Global Health Technologies Coalition (GHTC)
Every US$1 invested in #NTD research & development delivers an
estimated US$405 return. Investing in NTDs is not a cost - it's an
economic accelerator. We must protect this progress.
bit.ly/47Hexsl #BeatNTDs #NTDs #EndNTDs
November 19, 2025 at 9:30 PM
Impact Global Health estimates that USG cut $880m (18%) in global health R&D funding in 2025, amounting to an 8% drop in global funding. Without new or renewed funding, this could mean fewer future lifesaving tools for Americans & people around the world.

www.impactglobalhealth.org/insights/rep...
State of disunion: The impact of US funding cuts on global health R&D
This report offers a quantified assessment of the actual and potential impact of the 2025 US funding cuts giving a system-wide, data-driven picture of the ripple effects by disease, product, research ...
www.impactglobalhealth.org
November 19, 2025 at 9:03 PM
As we saw with #COVID19, an outbreak anywhere could quickly become a devastating pandemic. New #vaccines, #drugs, #diagnostics, and other tools are urgently needed to #OutsmartEpidemics. Learn more about technologies on the horizon💉💊🔬

www.ghtcoalition.org/rd-across-he...
Emerging Infectious Diseases
www.ghtcoalition.org
November 19, 2025 at 8:59 PM
A new study found that NIH grant terminations disrupted at least 383 clinical trials, including 74k+ patients, with international and infectious disease trials hit notably hard. Long term, these disruptions could limit future US-backed tools in key areas.

www.washingtonpost.com/health/2025/...
Trump slashed spending on clinical trials. The toll is starting to become clear.
Grants for 383 clinical trials were terminated and the funding disruptions affected more than 74,000 trial participants, according to new research.
www.washingtonpost.com
November 19, 2025 at 6:50 PM
Last week at the @astmh.bsky.social meeting, @mmv.org and Novartis shared the results of a Phase 3 study testing a new malaria treatment that was highly effective at treating malaria, including drug-resistant cases, and could also block disease transmission.

www.ghtcoalition.org/blog/researc...
Research Roundup: Rift Valley fever vaccine, Malaria treatment alternative, African-made cholera vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
November 19, 2025 at 2:13 PM
After a busy fall season of high-level gatherings for the global health community, GHTC is reflecting on our experiences at these convenings and how they are shaping our thinking about our role and path forward in these spaces.

www.ghtcoalition.org/blog/staying...
Staying the course amid change: Reflections on a season of global health engagement
After a busy fall season of high-level gatherings for the global health community, GHTC shared reflections on our experiences at these convenings and how they are shaping our thinking about the coalit...
www.ghtcoalition.org
November 18, 2025 at 9:03 PM